Skip to main content
 

Our Taxotere News

Below are some of our news stories explaining the potential dangers of the chemotherapy drug Taxotere, and especially the connection to permanent hair loss. To learn more about the types of injuries that have been linked to this medication, and the legal claims that have been filed, click Taxotere.

 

Unless the defendant Sanofi-Aventis reaches a global settlement, the first “bellwether” cases in current mass litigation over the chemotherapy drug Taxotere (docetaxel) will go before a…

One of the challenges when it comes to determining damages in injury lawsuits is putting a monetary value on intangible losses, such as pain and suffering, emotional distress, and anxiety. These…

In a development that is highly unusual in drug litigation, eight pharmaceutical companies involved in the manufacture and marketing of generic Taxotere (docetaxel) are now being named as…

Over the past two months, the number of lawsuits against Taxotere maker Sanofi-…

“Carla” (not her real name) is grateful to be a breast cancer survivor. She knew that the chemotherapy treatments would cause her hair to fall out – but she never thought that hair loss would be…

Drugs used in chemotherapy for cancer patients have numerous side effects, one of which is hair loss. In most cases, hair starts to grow back once the course of treatment is completed. However,…

Taxotere (docetaxel) is a chemotherapy drug that is part of the class known as taxanes. This class also includes Taxol (paclitaxel). Both drugs are mitotic inhibitors,…

Subscribe to Taxotere News
Customize This